Details for New Drug Application (NDA): 077651
✉ Email this page to a colleague
The generic ingredient in ZONISAMIDE is zonisamide. There are nineteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the zonisamide profile page.
Summary for 077651
Tradename: | ZONISAMIDE |
Applicant: | Glenmark Pharms Inc |
Ingredient: | zonisamide |
Patents: | 0 |
Pharmacology for NDA: 077651
Mechanism of Action | Carbonic Anhydrase Inhibitors P-Glycoprotein Inhibitors |
Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Suppliers and Packaging for NDA: 077651
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ZONISAMIDE | zonisamide | CAPSULE;ORAL | 077651 | ANDA | Proficient Rx LP | 63187-583 | 63187-583-30 | 30 CAPSULE in 1 BOTTLE (63187-583-30) |
ZONISAMIDE | zonisamide | CAPSULE;ORAL | 077651 | ANDA | Proficient Rx LP | 63187-583 | 63187-583-60 | 60 CAPSULE in 1 BOTTLE (63187-583-60) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 25MG | ||||
Approval Date: | Jan 30, 2006 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 50MG | ||||
Approval Date: | Jan 30, 2006 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
Approval Date: | Jan 30, 2006 | TE: | AB | RLD: | No |
Complete Access Available with Subscription